<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00093301</url>
  </required_header>
  <id_info>
    <org_study_id>03/007</org_study_id>
    <nct_id>NCT00093301</nct_id>
  </id_info>
  <brief_title>Levosimendan Versus Dobutamine in Shock Patients</brief_title>
  <official_title>Efficacy of Levosimendan in the Critically Ill Patients With Unstable Hemodynamics (the LICI Study) - A Double Blind Randomized Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wentworth Area Health Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Wentworth Area Health Services</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the efficacy of levosimendan with that of dobutamine
      in patients with unstable hemodynamics (shock).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2004</start_date>
  <completion_date>April 2006</completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Resolution of shock state</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in cardiac functions</measure>
  </secondary_outcome>
  <enrollment>40</enrollment>
  <condition>Cardiogenic Shock</condition>
  <condition>Septic Shock</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levosimendan</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dobutamine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Reduced left ventricular systolic function

          -  Hypotension

          -  Anuria or oligouria

        Exclusion Criteria:

          -  Less than 18 years old

          -  Pregnant

          -  Uncorrected valvular stenosis

          -  Hypertrophic obstructive cardiomyopathy (HOCM)

          -  Third degree AV block
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Intensive Care Unit, Nepean Hospital</name>
      <address>
        <city>Penrith</city>
        <state>New South Wales</state>
        <zip>2750</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony S McLean, MD</last_name>
      <phone>+61-2-47342490</phone>
      <email>mcleana@wahs.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Stephen J Huang, PhD</last_name>
      <phone>+61-247342320</phone>
      <email>huangs@wahs.nsw.gov.au</email>
    </contact_backup>
    <investigator>
      <last_name>Anthony S McLean, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen J Huang, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ian Seppelt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marek Nalos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>October 2004</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2004</study_first_submitted>
  <study_first_submitted_qc>October 6, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2004</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <keyword>Shock</keyword>
  <keyword>Levosimendan</keyword>
  <keyword>Inotropes</keyword>
  <keyword>Dobutamine</keyword>
  <keyword>Heart failure</keyword>
  <keyword>Sepsis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock, Cardiogenic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simendan</mesh_term>
    <mesh_term>Dobutamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

